| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Rosa David J. | 228.8K | $115.33M | - |
| Other | GUTHART GARY S | 49.2K | $24.79M | - |
| Other | 25.5K | $12.85M | - | |
| VP | DeSantis Robert | 17.0K | $8.59M | - |
| Dir | RUBASH MARK J | 16.8K | $8.46M | - |
| VP | Miller Brian Edward | 16.2K | $8.16M | - |
| Pres | 11.4K | $5.77M | - | |
| VP | Charlton Henry L | 9.8K | $4.94M | - |
| Dir | NACHTSHEIM JAMI K | 8.8K | $4.42M | - |
| VP | 8.4K | $4.25M | - | |
| Other | 8.1K | $4.07M | - | |
| VP | 7.1K | $3.56M | - | |
| VP | LOEB GARY | 4.9K | $2.45M | - |
| VP | Curet Myriam | 4.9K | $2.45M | - |
| VP | 4.5K | $2.26M | - | |
| VP | 1.9K | $947.6K | - | |
| Dir | 750 | $378.0K | - | |
| Dir | BARRATT CRAIG H | 750 | $378.0K | - |
| Dir | Leonard Keith R | 739 | $372.5K | - |
| Dir | Ladd Amy L | 739 | $372.5K | - |
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2023-04-21 | Widman Fredrik | VP Corporate Controller | Sell | 630 | $297.87 | $187,658.10 | -22.0% | → |
| 2023-04-21 | RUBASH MARK J | Director | Sale+OE | 8,135 | $297.93 | $2,423,688.80 | -3.5% | → |
| 2023-04-21 | BARRATT CRAIG H | Director | Sale+OE | 6,000 | $297.92 | $1,787,524.20 | -100% | → |
| 2023-04-21 | RUBASH MARK J | Director | Sale+OE | 1,220 | $297.93 | $363,476.31 | -2.0% | → |
| 2023-04-21 | DeSantis Robert | EVP & Chief Product Officer | Sale+OE | 8,623 | $297.92 | $2,568,980.62 | -12.1% | → |
| 2023-04-21 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 9,623 | $299.76 | $2,884,579.45 | -65.5% | → |
| 2023-04-21 | Rosa David J. | EVP Chief Strategy & Growth Of | Sale+OE | 40,800 | $297.92 | $12,155,172.72 | -22.3% | → |
| 2023-03-01 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 1,253 | $228.47 | $286,272.91 | -39.1% | → |
| 2023-02-16 | Widman Fredrik | VP Corporate Controller | Sell | 116 | $240.77 | $27,929.32 | -6.7% | → |
| 2023-02-16 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 1,124 | $240.77 | $270,625.48 | -77.5% | → |
| 2023-02-16 | DeSantis Robert | EVP & Chief Product Officer | Sale+OE | 1,971 | $240.77 | $474,557.67 | -23.6% | → |
| 2023-02-13 | MOHR MARSHALL | Executive VP Global Business S | Sale+OE | 33,249 | $245.61 | $8,166,376.66 | -61.6% | → |
| 2023-02-13 | Widman Fredrik | VP Corporate Controller | Sell | 1,307 | $246.09 | $321,639.63 | -46.7% | → |
| 2023-02-06 | Rosa David J. | EVP Chief Strategy & Growth Of | Sale+OE | 45,025 | $250.53 | $11,280,023.20 | -26.4% | → |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer | Sale+OE | 1,629 | $250.00 | $407,250.00 | -10.7% | → |
| 2022-11-08 | Johnson Amal M | Director | Sale+OE | 6,375 | $239.36 | $1,525,904.06 | -36.2% | → |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 8,000 | $250.06 | $2,000,508.80 | -94.9% | → |
| 2022-10-21 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 8,000 | $209.78 | $1,678,242.40 | -94.9% | → |
| 2022-10-21 | GUTHART GARY S | President & CEO | Sale+OE | 44,203 | $210.84 | $9,319,610.23 | -65.5% | → |